Aarti Drugs Ltd (AARTIDRUGS) Stock Price & News

AARTIDRUGS:NSE

Aarti Drugs Ltd

₹446.05

+0.20%

(+0.90) 1D

Nov 6, 3:30:00 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Last report

Nov 4, 2026

Fiscal period

Q2 2027

- / -

Revenue / Est. (INR)

8.29B / -

Fiscal Q2 2027 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in INR

Loading Previous Earnings...

All values in INR	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	6.02B	7.20B	7.03B	8.29B
Cost of goods sold	3.87B	4.75B	4.28B	4.99B
Cost of revenue	3.87B	4.75B	4.28B	4.99B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	331.60M	353.24M	365.10M	371.30M
Operating expense	1.77B	1.69B	1.95B	2.11B
Total operating expenses	5.63B	6.44B	6.22B	7.10B
Operating income	383.20M	761.27M	805.50M	1.19B
Other non operating income	16.00K	12.15M	-	-100.00K
EBT including unusual items	290.32M	703.57M	692.40M	1.09B
EBT excluding unusual items	290.32M	703.57M	713.30M	1.09B
Income tax expense	-115.20M	150.94M	191.10M	265.10M
Effective tax rate	-39.68%	21.45%	27.60%	24.26%
Other operating expenses	1.26B	1.16B	1.40B	1.55B
Net income	405.40M	551.97M	501.70M	829.40M
Net profit margin	6.74%	7.66%	7.14%	10.01%
Earnings per share	-	-	5.66	-
Interest and investment income	-	11.69M	-	-
Interest expense	-92.90M	-81.55M	-92.20M	-96.30M
Net interest expenses	-92.90M	-69.85M	-92.20M	-96.30M
Depreciation and amortization charges	179.50M	180.41M	184.60M	190.00M
EBITDA	515.81M	916.49M	972.92M	1.38B
Gain or loss from assets sale	-	-	-	-

Finance